Roche Increases Investment in US Mfg Facility to $2 Bn
By
Roche’s Genentech will more than double its initial investment in a biomanufacturing facility in Holly Springs, North Carolina, to approximately $2 billion, bolstering Roche’s and Genentech’s $50-billion investment in US manufacturing and R&D. The expansion…
